Predict your next investment

Other

See what CB Insights has to offer

Investments

1

Portfolio Exits

1

About GCB

GCB Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

GCB Investments

1 Investments

GCB has made 1 investments. Their latest investment was in Epitomee Medical as part of their Unattributed VC on April 4, 2019.

CBI Logo

GCB Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/9/2019

Unattributed VC

Epitomee Medical

$8M

Yes

4

Date

4/9/2019

Round

Unattributed VC

Company

Epitomee Medical

Amount

$8M

New?

Yes

Co-Investors

Sources

4

GCB Portfolio Exits

1 Portfolio Exit

GCB has 1 portfolio exit. Their latest portfolio exit was Epitomee Medical on December 16, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/16/2021

IPO

$99M

1

Date

12/16/2021

Exit

IPO

Companies

Valuation

$99M

Acquirer

Sources

1

GCB Team

1 Team Member

GCB has 1 team member, including former Owner, Carter Malloy.

Name

Work History

Title

Status

Carter Malloy

Stephens

Owner

Former

Name

Carter Malloy

Work History

Stephens

Title

Owner

Status

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.